Amphastar P (AMPH) stock news · P/E 15, rev $719.9M
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This AMPH news page leads with what Amphastar P filed — not a scraped headline mill.
No cached 8-K sentence for AMPH yet. We will not pad this page with generic market recap.
Latest reported AMPH revenue for 2025-12-31 was $719.9M. Net income was $98.1M. Revenue was down 1.7% from 2024-12-31 to 2025-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 15.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AMPH stock page; for the tape open the quote page.
AMPH stock news FAQ
What are AMPH's latest revenue and net income?
Latest cached Amphastar P (AMPH) revenue for Dec 31, 2025 was $719.9M. Net income was $98.1M. Statements: https://lician.com/financials/amph
How did AMPH revenue change from the prior cached period?
Cached Amphastar P (AMPH) revenue was down 1.7% from $732.0M (Dec 31, 2024) to $719.9M (Dec 31, 2025). Statements: https://lician.com/financials/amph
What is AMPH's P/E ratio?
Amphastar P (AMPH) trailing P/E is 15.3 on the latest cached fundamentals snapshot.
What is AMPH's market cap?
Amphastar P (AMPH) market cap is $880.1M on the latest cached fundamentals snapshot.
What kind of company is AMPH?
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is AMPH stock news listed?
Cached stock news for Amphastar P (AMPH) is listed at https://lician.com/news/amph. Filings: https://lician.com/sec/amph
Not investment advice.